Department of Obstetrics and Gynaecology

Comparative analysis of tumour mutational burden (TMB) prediction methods and its association with determinants of the tumour immune microenvironment of urothelial bladder cancer (UBC) (2019) Eckstein M, Hartmann A, Strissel P, Strick R, Wach S, Taubert H, Wullich B, et al. Conference contribution Ventral rectopexy with biological mesh for recurrent disorders of the posterior pelvic organ compartment (2019) Brunner M, Roth H, Günther K, Grützmann R, Matzel KE Journal article Salivary and hair cortisol as biomarkers of emotional and behavioral symptoms in 6–9 year old children (2019) Golub Y, Kuitunen-Paul S, Panaseth K, Stonawski V, Frey S, Steigleder R, Grimm J, et al. Journal article Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431)) (2019) Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, et al. Journal article, Erratum Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy (2019) Schrauder MG, Brunel-Geuder L, Häberle L, Wunderle M, Hoyer J, Csorba R, Reis A, et al. Journal article Nab-paclitaxel improves disease-free survival in early breast cancer: GBG 69–Geparsepto (2019) Untch M, Jackisch C, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, Schem C, et al. Journal article Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study (2019) Hurvitz SA, Martin M, Jung KH, Huang CS, Harbeck N, Valero V, Stroyakovskiy D, et al. Journal article Ultrasound Fetal Weight Estimation in Diabetic Pregnancies (2019) Pretscher J, Kehl S, Stumpfe FM, Mayr A, Schmid M, Schild RL, Beckmann M, Faschingbauer F Journal article Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy (2019) Lotz L, Dittrich R, Hoffmann I, Beckmann M Journal article A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: Clinical results and biomarker analysis of GeparNuevo study (2019) Loibl S, Untch M, Burchardi N, Huober J, Sinn BV, Blohmer JU, Grischke EM, et al. Journal article